GSK3 Inhibitors Regulate MYCN mRNA Levels and Reduce Neuroblastoma Cell Viability through Multiple Mechanisms, Including p53 and Wnt Signaling

Research output: Contribution to journal › Article › peer-review

Standard Standard

GSK3 Inhibitors Regulate MYCN mRNA Levels and Reduce Neuroblastoma Cell Viability through Multiple Mechanisms, Including p53 and Wnt Signaling. / Duffy, David J.; Krstic, Aleksandar; Schwarzl, Thomas et al.
In: Mol. Cancer Ther., Vol. 13, No. 2, 02.2014, p. 454-467.

Research output: Contribution to journal › Article › peer-review

HarvardHarvard

Duffy, DJ, Krstic, A, Schwarzl, T, Higgins, DG & Kolch, W 2014, 'GSK3 Inhibitors Regulate MYCN mRNA Levels and Reduce Neuroblastoma Cell Viability through Multiple Mechanisms, Including p53 and Wnt Signaling', Mol. Cancer Ther., vol. 13, no. 2, pp. 454-467. https://doi.org/10.1158/1535-7163.MCT-13-0560-T

APA

Duffy, D. J., Krstic, A., Schwarzl, T., Higgins, D. G., & Kolch, W. (2014). GSK3 Inhibitors Regulate MYCN mRNA Levels and Reduce Neuroblastoma Cell Viability through Multiple Mechanisms, Including p53 and Wnt Signaling. Mol. Cancer Ther., 13(2), 454-467. https://doi.org/10.1158/1535-7163.MCT-13-0560-T

CBE

Duffy DJ, Krstic A, Schwarzl T, Higgins DG, Kolch W. 2014. GSK3 Inhibitors Regulate MYCN mRNA Levels and Reduce Neuroblastoma Cell Viability through Multiple Mechanisms, Including p53 and Wnt Signaling. Mol. Cancer Ther. 13(2):454-467. https://doi.org/10.1158/1535-7163.MCT-13-0560-T

MLA

Duffy, David J. et al. "GSK3 Inhibitors Regulate MYCN mRNA Levels and Reduce Neuroblastoma Cell Viability through Multiple Mechanisms, Including p53 and Wnt Signaling". Mol. Cancer Ther. 2014, 13(2). 454-467. https://doi.org/10.1158/1535-7163.MCT-13-0560-T

VancouverVancouver

Duffy DJ, Krstic A, Schwarzl T, Higgins DG, Kolch W. GSK3 Inhibitors Regulate MYCN mRNA Levels and Reduce Neuroblastoma Cell Viability through Multiple Mechanisms, Including p53 and Wnt Signaling. Mol. Cancer Ther. 2014 Feb;13(2):454-467. Epub 2013 Nov 26. doi: 10.1158/1535-7163.MCT-13-0560-T

Author

Duffy, David J. ; Krstic, Aleksandar ; Schwarzl, Thomas et al. / GSK3 Inhibitors Regulate MYCN mRNA Levels and Reduce Neuroblastoma Cell Viability through Multiple Mechanisms, Including p53 and Wnt Signaling. In: Mol. Cancer Ther. 2014 ; Vol. 13, No. 2. pp. 454-467.

RIS

TY - JOUR

T1 - GSK3 Inhibitors Regulate MYCN mRNA Levels and Reduce Neuroblastoma Cell Viability through Multiple Mechanisms, Including p53 and Wnt Signaling

AU - Duffy, David J.

AU - Krstic, Aleksandar

AU - Schwarzl, Thomas

AU - Higgins, Desmond G.

AU - Kolch, Walter

PY - 2014/2

Y1 - 2014/2

U2 - 10.1158/1535-7163.MCT-13-0560-T

DO - 10.1158/1535-7163.MCT-13-0560-T

M3 - Article

VL - 13

SP - 454

EP - 467

JO - Mol. Cancer Ther.

JF - Mol. Cancer Ther.

SN - 1535-7163

IS - 2

ER -